How will the move in Share Market this week, which shares will be focus | Paisa Live


Last week, the stock market saw a decline for the second consecutive week. BSE Sensex closed 742.74 points i.e. 0.90% and NSE NIFTY 181.45 points or 0.72% below. The main reason behind this decline was the pressure of the quarterly results of the companies, which had a negative impact on many stocks. Also, heavy selling by foreign institutional investors (FII) also affected market sentiments. FII has sold more than Rs 10,169 crore in the last few days, which led to weakness in the market, although the coming week can be very important for the market. On Monday, the quarterly results of veteran companies like Reliance Industries, HDFC Bank and ICICI Bank are coming, and good results of these companies are expected to be expected, which may have a positive impact on the market. Apart from this, the results of companies like Ultrate Cement, Infosys, Eternal, Bajaj Finance and Nestle are also coming, which will impact the market direction. The same India-US trade talk can start before 1 August, which can provide relief to the market. However, India may also have to face some negative impact due to former US President Donald Trump’s strict attitude towards BRICS countries. Overall, there is a possibility of ups and downs for the upcoming week market."pointer-events-none h-px w-px" aria-hidden="true" data-edge="true"> 



Source link

support@headlinenews360.com

Related Posts

Will the market crash after the announcement of President Trump’s new tariff on India? Learn what you are getting

Stock Market Today: The Indian domestic market is visible on Thursday, 31 July 2025, a day after the announcement of imposing 25 percent tariff on Indian goods. These new rates…

Top stocks to buy today: Stock recommendations for July 31, 2025 – check list – Times of India

Top stocks to buy today (AI image) Top stock market recommendations: According to Aakash K Hindocha, Deputy Vice President – WM Research, Nuvama Professional Clients Group, Jindal SteelAjanta Pharma, and…

Leave a Reply

Your email address will not be published. Required fields are marked *